De Novo Lipogenesis Maintains Vascular Homeostasis through Endothelial Nitric-oxide Synthase (eNOS) Palmitoylation*♦
暂无分享,去创建一个
J. Schneider | D. Towler | C. Semenkovich | J. Vita | M. Chakravarthy | Joseph A Vita | Clay F Semenkovich | Dwight A Towler | Sherene M Shenouda | Xiaochao Wei | Jochen G Schneider | Ada Lee | Manu V Chakravarthy | Sherene M. Shenouda | Xiaochao Wei | Ada Lee
[1] T. Hughes,et al. Trafficking of Endothelial Nitric-oxide Synthase in Living Cells , 1999, The Journal of Biological Chemistry.
[2] Timm Maier,et al. The Crystal Structure of a Mammalian Fatty Acid Synthase , 2008, Science.
[3] P. Shaul. Regulation of endothelial nitric oxide synthase: location, location, location. , 2002, Annual review of physiology.
[4] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[5] M. Quon,et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. , 2000, Circulation.
[6] D. Bredt,et al. Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase , 2006, The Journal of cell biology.
[7] A. Baron,et al. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. , 2000, Diabetes.
[8] Hei Sook Sul,et al. A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin , 2009, Cell.
[9] M. Moskowitz,et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.
[10] R. Knutsen,et al. Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice , 2003, Nature Medicine.
[11] J. Pankow,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[12] Jeffrey W. Smith,et al. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] A. Aljada,et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.
[14] N. Toda,et al. Phylogenesis of constitutively formed nitric oxide in non-mammals. , 2006, Reviews of physiology, biochemistry and pharmacology.
[15] M. Moskowitz,et al. Obesity Increases Vascular Senescence and Susceptibility to Ischemic Injury Through Chronic Activation of Akt and mTOR , 2009, Science Signaling.
[16] Tiffany A. Miller,et al. Insulin acutely decreases hepatic fatty acid synthase activity. , 2005, Cell metabolism.
[17] S. Chirala,et al. Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] T. Iwanaga,et al. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. , 2010, Cell metabolism.
[19] T. Michel,et al. Targeting and translocation of endothelial nitric oxide synthase. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[20] M. Salis,et al. Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice. , 2004, Diabetes.
[21] R. Flavell,et al. Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice , 2001, The Journal of experimental medicine.
[22] M. Loda,et al. Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer , 2008, Laboratory Investigation.
[23] M. Zou,et al. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. , 2006, The Journal of clinical investigation.
[24] T. Michel,et al. Life history of eNOS: partners and pathways. , 2007, Cardiovascular research.
[25] L. Ghiadoni,et al. Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease , 2009, Diabetes Care.
[26] S. Mader,et al. Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney , 2006, Diabetes.
[27] C. Semenkovich,et al. Getting away from glucose: stop sugarcoating diabetes , 2009, Nature Medicine.
[28] G. Garcı́a-Cardeña,et al. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. , 1996, Biochemistry.
[29] J. Schneider,et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.
[30] Yoshiaki Suzuki,et al. p260/270 Expressed in Embryonic Abdominal Leg Cells ofBombyx mori Can Transfer Palmitate to Peptides* , 1997, The Journal of Biological Chemistry.
[31] Benjamin J. Kraus,et al. Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[32] John P. Cooke,et al. Murine Model of Hindlimb Ischemia , 2009, Journal of visualized experiments : JoVE.
[33] A. Bailey,et al. Palmitoylated proteins: purification and identification , 2007, Nature Protocols.
[34] U. Förstermann,et al. Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace , 2006, Circulation.
[35] T. Tsuruo,et al. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy , 2009, British Journal of Cancer.
[36] N. Hay,et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo , 2005, Nature Medicine.
[37] S. Wakil,et al. Fatty acid synthase, a proficient multifunctional enzyme. , 1989, Biochemistry.
[38] S. Ropero,et al. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Garcı́a-Cardeña,et al. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] A. Tsai,et al. Three Different Oxygen-induced Radical Species in Endothelial Nitric-oxide Synthase Oxygenase Domain under Regulation by L-Arginine and Tetrahydrobiopterin* , 2004, Journal of Biological Chemistry.
[41] J. Banchs,et al. Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. , 2002, Journal of applied physiology.
[42] M. Schuler,et al. Peptides from purified soybean β‐conglycinin inhibit fatty acid synthase by interaction with the thioesterase catalytic domain , 2010, The FEBS journal.
[43] Marjana Tomic-Canic,et al. Cellular and molecular basis of wound healing in diabetes. , 2007, The Journal of clinical investigation.